161 related articles for article (PubMed ID: 38671458)
1. The value of low-intensity pulsed ultrasound in reducing ovarian injury caused by chemotherapy in mice.
Zhou Y; Zhu F; Zhou Y; Li X; Zhao S; Zhang Y; Zhu Y; Li H; Cao Y; Zhang C
Reprod Biol Endocrinol; 2024 Apr; 22(1):51. PubMed ID: 38671458
[TBL] [Abstract][Full Text] [Related]
2. Effects of low-intensity pulsed ultrasound (LIPUS)-pretreated human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation on primary ovarian insufficiency in rats.
Ling L; Feng X; Wei T; Wang Y; Wang Y; Zhang W; He L; Wang Z; Zeng Q; Xiong Z
Stem Cell Res Ther; 2017 Dec; 8(1):283. PubMed ID: 29258619
[TBL] [Abstract][Full Text] [Related]
3. Effects of low intensity pulsed ultrasound on expression of B-cell lymphoma-2 and BCL2-Associated X in premature ovarian failure mice induced by 4-vinylcyclohexene diepoxide.
Xu H; Xia Y; Qin J; Xu J; Li C; Wang Y
Reprod Biol Endocrinol; 2021 Jul; 19(1):113. PubMed ID: 34284777
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice.
Qin Y; Iwase A; Murase T; Bayasula ; Ishida C; Kato N; Nakamura T; Osuka S; Takikawa S; Goto M; Kotani T; Kikkawa F
Reprod Biol Endocrinol; 2018 Oct; 16(1):106. PubMed ID: 30368246
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin.
Morgan S; Lopes F; Gourley C; Anderson RA; Spears N
PLoS One; 2013; 8(7):e70117. PubMed ID: 23922929
[TBL] [Abstract][Full Text] [Related]
6. Effects of Low-Intensity Pulsed Ultrasound on the Migration and Homing of Human Amnion-Derived Mesenchymal Stem Cells to Ovaries in Rats With Premature Ovarian Insufficiency.
Ling L; Hou J; Wang Y; Shu H; Huang Y
Cell Transplant; 2022; 31():9636897221129171. PubMed ID: 36282038
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes.
Nguyen QN; Zerafa N; Liew SH; Findlay JK; Hickey M; Hutt KJ
Mol Hum Reprod; 2019 Aug; 25(8):433-444. PubMed ID: 30953068
[TBL] [Abstract][Full Text] [Related]
8. The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells.
Yuksel A; Bildik G; Senbabaoglu F; Akin N; Arvas M; Unal F; Kilic Y; Karanfil I; Eryılmaz B; Yilmaz P; Ozkanbaş C; Taskiran C; Aksoy S; Guzel Y; Balaban B; Ince U; Iwase A; Urman B; Oktem O
Hum Reprod; 2015 Dec; 30(12):2926-35. PubMed ID: 26466914
[TBL] [Abstract][Full Text] [Related]
9. Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice.
Huang J; Shan W; Li N; Zhou B; Guo E; Xia M; Lu H; Wu Y; Chen J; Wang B; Xi L; Ma D; Chen G; Li K; Sun C
Reprod Biomed Online; 2021 Mar; 42(3):505-519. PubMed ID: 33388265
[TBL] [Abstract][Full Text] [Related]
10. LIPUS combined with TFSC alleviates premature ovarian failure by promoting autophagy and inhibiting apoptosis.
Zhou W; Chen A; Ye Y; Ren Y; Lu J; Xuan F; Jin R
Gynecol Endocrinol; 2023 Dec; 39(1):2258422. PubMed ID: 37855244
[TBL] [Abstract][Full Text] [Related]
11. Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage.
Wu Y; Ma C; Zhao H; Zhou Y; Chen Z; Wang L
Reprod Biol Endocrinol; 2018 Sep; 16(1):85. PubMed ID: 30176887
[TBL] [Abstract][Full Text] [Related]
12. Effect of therapeutic ultrasound on folliculogenesis, angiogenesis and apoptosis after heterotopic mouse ovarian transplantation.
Abtahi NS; Eimani H; Vosough A; Shahverdi A; Fathi R; Hayati N; Nasiri N
Ultrasound Med Biol; 2014 Jul; 40(7):1535-44. PubMed ID: 24785439
[TBL] [Abstract][Full Text] [Related]
13. C-Abl is not actıvated in DNA damage-induced and Tap63-mediated oocyte apoptosıs in human ovary.
Bildik G; Acılan C; Sahin GN; Karahuseyinoglu S; Oktem O
Cell Death Dis; 2018 Sep; 9(10):943. PubMed ID: 30237472
[TBL] [Abstract][Full Text] [Related]
14. Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility.
Nguyen QN; Zerafa N; Liew SH; Morgan FH; Strasser A; Scott CL; Findlay JK; Hickey M; Hutt KJ
Cell Death Dis; 2018 May; 9(6):618. PubMed ID: 29795269
[TBL] [Abstract][Full Text] [Related]
15. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin preserves the primordial follicle pool during cisplatin treatment in vitro and in vivo.
Xie Y; Li S; Zhou L; Lin H; Jiao X; Qiu Q; Liang Y; Zhang Q
Mol Reprod Dev; 2020 Apr; 87(4):442-453. PubMed ID: 32112509
[TBL] [Abstract][Full Text] [Related]
17. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol protects against cisplatin-induced ovarian and uterine toxicity in female rats by attenuating oxidative stress, inflammation and apoptosis.
Ibrahim MA; Albahlol IA; Wani FA; Abd-Eltawab Tammam A; Kelleni MT; Sayeed MU; Abd El-Fadeal NM; Mohamed AA
Chem Biol Interact; 2021 Apr; 338():109402. PubMed ID: 33587916
[TBL] [Abstract][Full Text] [Related]
19. [Effect of low intensity pulsed ultrasound on expression of TGF-β1 and Smads during dentin injury and repair].
Wang F; Zuo J; Li Y; Yang Z; Luo J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1030-1036. PubMed ID: 28989147
[TBL] [Abstract][Full Text] [Related]
20. Progesterone decreases the extent of ovarian damage caused by cisplatin in an experimental rat model.
Ozdamar S; Taskin MI; Onder GO; Kaymak E; Baran M; Yay A
Adv Clin Exp Med; 2019 Jan; 28(1):25-33. PubMed ID: 30066501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
